The Trump administration is reviewing a contract extended to Moderna in the final days of the Biden administration.

Moderna Inc.'s stock tumbled 4% Thursday, after a report that health officials are reviewing a contract the company won from the Biden administration to support its efforts to develop a bird-flu ...

Moderna (NASDAQ: MRNA) became a hot investment during the pandemic as its COVID vaccine made investors bullish on its future.

US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to ...

The FDA canceled a vaccine advisory committee meeting to discuss influenza virus strains that should be included in shots for ...

The administration also told Vaxart Inc. to halt its research on an oral Covid vaccine, Bloomberg reports. In related news, the policy to cull poultry caught in H5N1 bird flu outbreaks will not be ...

Moderna is one of the pharmaceutical companies best known for developing the messenger RNA vaccine against Covid-19.

Moderna’s reliance on its COVID vaccine for revenue has become a vulnerability as sales decline and the company invests heavily in its product pipeline. The bird flu vaccine contract was expedited due ...

U.S. health officials are reevaluating a $590M bird flu vaccine contract that was awarded to Moderna ( NASDAQ: MRNA) by the ...

Nvidia said sales, driven by the chips that power artificial intelligence, rose 78% to $39.3 billion in its latest quarter. Net income rose 80% to $22 billion. Both figures came in ahead of Wall ...

Eli Lilly plans to invest $27 billion in new U.S. plants amidst threats of drug import tariffs by the Trump administration.

U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird ...